Obama nominates Califf as FDA commissioner
The Food and Drug Administration’s current deputy commissioner for medical products and tobacco is likely to become the organization’s next commissioner. Dr.
Pharmacy
Camber adds Valtrex, Aricept generics
Camber Pharmaceuticals has expanded its generic drug portfolio with the rollout of valacyclovir and donepezil HCl tablets. The company said Wednesday that its valacyclovir product is a generic version of GlaxoSmithKline’s Valtrex, while its donepezil HCl product is a generic of Eisai Co.’s Aricept.
McNeil Consumer Healthcare becomes NCPDP Elite Partner
McNeil Consumer Healthcare has joined the National Council for Prescription Drug Programs (NCPDP) Elite Partner Program. NCPDP said Wednesday that the Elite Partner Program establishes the highest level of sustained support for the council’s efforts to advance patient safety and interoperability.
Albertsons expands Rx distribution with McKesson
Food and drug retailer Albertsons has signed a five-year distribution pact for the sourcing and distribution of branded and generic drugs with McKesson Corp. The companies said late Tuesday that the pharmaceutical distribution agreement will go into effect on April 1, 2016.
Neighbourhood Pharmacies introduces the Pharmacy Expo
The Neighbourhood Pharmacy Association of Canada has enhanced its annual events program, including the launch of the Pharmacy Expo, an expansion of its major annual spring gathering.
Cardinal Health debuts Hospital Quality at Home brand
Cardinal Health Inc. has unveiled a new home health care line called Hospital Quality at Home, which includes a range of over-the-counter products to help patients transition care from the hospital to their home.
Bartell Drugs kicks off flu vaccine program
Bartell Drugs has launched a seasonal flu shot program that offers vaccinations at all of its 64 stores as well as via an off-site flu clinic program serving area businesses and retirement communities.
London Drugs helps Canadians get immunized
Pharmacists at London Drugs are working with the Canadian Medical Association (CMA) to help educate parents about immunization options as their children head back to school.
Bayer names new North America president for Consumer Care
Veteran health care products executive Natalie Bartner has joined Bayer HealthCare as president of Bayer Consumer Care, North America.
Mylan takes hostile bid to Perrigo stockholders
As promised, Mylan N.V. has proceeded to make formal bid to acquire Perrigo Co. plc in a deal valued at approximately $27 billion. Mylan said Monday that under the offer, Perrigo shareholders would receive $75 in cash and 2.3 Mylan ordinary shares for each Perrigo ordinary share.
NCPA to roll out lab test platform for pharmacies
Community pharmacies will be able to offer patients direct access to lab tests and health screenings via a partnership announced by the National Community Pharmacists Association.
Diplomat sells compounding pharmacy operation
Personalized medicine solution provider Restore Health plans to acquire the compounding pharmacy assets of Diplomat Pharmacy Inc. Financial terms of the agreement weren’t disclosed.
Express Scripts announces CEO succession
Next spring, George Paz is slated to retire as chief executive officer of Express Scripts Holding Co. and be succeeded by president Tim Wentworth.
Yasmin generic released by Mylan
Mylan N.V. has announced the U.S. launch of drospirenone and ethinyl estradiol tablets (3 mg/0.03 mg), an oral contraceptive.
NACDS, PhRMA help weigh impact of Rx use on Medicaid costs
The National Association of Chain Drug Stores and the Pharmaceutical Research and Manufacturers of America (PhRMA) co-authored a Health Affairs article on research finding that when prescription drugs are taken as directed by a physician, other medical costs are reduced for certain Medicaid benefici
Mylan to make acquisition bid to Perrigo shareholders
Next week, Mylan N.V. plans to make a formal offer directly to the shareholders of Perrigo plc to buy the company. Mylan said Tuesday that it aims to make the bid on Monday, Sept. 14. Under the offer, Perrigo shareholders would receive $75 in cash and 2.3 Mylan ordinary shares for each